Additional safety signals have been identified with apremilast, with some adverse events specific to certain patient populations.

Readers respond to a psychiatrist’s essay arguing for more research on the effects of S.S.R.I.s like Prozac and other drugs.

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.